Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review) - Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
被引:252
作者:
Simpson, D. M.
论文数: 0引用数: 0
h-index: 0
机构:
Mt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USAMt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USA
Simpson, D. M.
[1
]
Gracies, J. -M.
论文数: 0引用数: 0
h-index: 0
机构:
CHU Henri Mondor, Dept Rehabil Med, F-94010 Creteil, FranceMt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USA
Gracies, J. -M.
[2
]
Graham, H. K.
论文数: 0引用数: 0
h-index: 0
机构:Mt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USA
Graham, H. K.
Miyasaki, J. M.
论文数: 0引用数: 0
h-index: 0
机构:
Toronto Western Hosp, Toronto, ON, CanadaMt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USA
Miyasaki, J. M.
[3
]
Naumann, M.
论文数: 0引用数: 0
h-index: 0
机构:
Klinikum Augsburg, Dept Neurol, Augsburg, GermanyMt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USA
Naumann, M.
[4
]
Russman, B.
论文数: 0引用数: 0
h-index: 0
机构:
Shriners Hosp Children, Portland, OR 97201 USAMt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USA
Russman, B.
[5
]
Simpson, L. L.
论文数: 0引用数: 0
h-index: 0
机构:
Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USAMt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USA
Simpson, L. L.
[6
]
So, Y.
论文数: 0引用数: 0
h-index: 0
机构:
Stanford Univ, Stanford, CA 94305 USAMt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USA
So, Y.
[7
]
机构:
[1] Mt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USA
[2] CHU Henri Mondor, Dept Rehabil Med, F-94010 Creteil, France
Objective: To perform an evidence-based review of the safety and efficacy of botulinum neurotoxin (BoNT) in the treatment of adult and childhood spasticity. Methods: A literature search was performed including MEDLINE and Current Contents for therapeutic articles relevant to BoNT and spasticity. Authors reviewed, abstracted, and classified articles based on American Academy of Neurology criteria (ClassI-IV). Results: The highest quality literature available for the respective indications was as follows: adult spasticity (14 Class I studies); spastic equinus and adductor spasticity in pediatric cerebral palsy (six Class I studies). Recommendations: Botulinum neurotoxin should be offered as a treatment option for the treatment of spasticity in adults and children (Level A).